Malaria prophylaxis policy for travellers from Europe to the Indian Sub Continent
Open Access
- 1 February 2006
- journal article
- editorial
- Published by Springer Nature in Malaria Journal
- Vol. 5 (1), 7
- https://doi.org/10.1186/1475-2875-5-7
Abstract
Analysis of malaria imported into eight European countries from the Indian sub-continent (ISC) (India, Pakistan, Bangladesh and Sri Lanka) led to a consensus statement on the use of chemoprophylaxis within TropNetEurop. The proportion of cases from the ISC in 2004 ranged from 1.4%–4.6% of total imported cases. Plasmodium falciparum cases reported from the eight countries was only 23 (13% of all cases from the region). Total malaria reports between 1999–2004 fell from 317 to 180. The risk of malaria in UK residents visiting the region was > 1 case per 1,000 years exposed. The group recommended non-selective prescribing of chemoprophylaxis for visitors to India, Pakistan, Bangladesh and Sri Lanka should be dropped.Keywords
This publication has 4 references indexed in Scilit:
- Who Needs Drug Prophylaxis against Malaria? My Personal ViewJournal of Travel Medicine, 2006
- Knowledge, Attitudes and Practices in Travel-related Infectious Diseases: The European Airport SurveyJournal of Travel Medicine, 2004
- Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEuropMalaria Journal, 2004
- Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm studyBMJ, 2003